Safety and efficacy of interferon-α in 167 patients with human T-cell lymphotropic virus type 1-associated myelopathy

Journal of NeuroVirology

Volumn 13, Issue 4, 2007, Pages 364-372

  Arimura, Kimiyoshi ^a   Nakagawa, Masanori ^b   Izumo, Shuji ^c   Usuku, Koichiro ^d   Itoyama, Yasuto ^e   Kira, Jun Ichi ^f   Osame, Mitsuhiro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

^d KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

^e TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f KYUSHU UNIVERSITY   (Japan)

Author keywords

Adverse reactions; HAM; Interferon ; Postmarketing surveillance; Provision factor; Sustained effect

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASE; CORTICOSTEROID; MECOBALAMIN; MUSCLE RELAXANT AGENT;

ADULT; AGED; ANEMIA; ANOREXIA; ARTICLE; BACKACHE; BRAIN HEMORRHAGE; CLINICAL FEATURE; CLONUS; CONSCIOUSNESS DISORDER; CONTROLLED STUDY; DECREASED APPETITE; DEPRESSION; DISEASE DURATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ERUPTION; DRUG FATALITY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG INTERMITTENT THERAPY; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; DYSESTHESIA; EPIGLOTTITIS; FACTORIAL ANALYSIS; FEMALE; FLACCID PARALYSIS; GAIT DISORDER; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HYPERESTHESIA; HYPERGLYCEMIA; HYPERTHYROIDISM; HYPOKALEMIA; HYPOTENSION; LEUKOCYTE COUNT; LIVER FUNCTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALAISE; MALE; MOTOR DYSFUNCTION; NAUSEA; OUTCOME ASSESSMENT; PANCYTOPENIA; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; SCORING SYSTEM; SHOCK; SIDE EFFECT; SPINAL CORD INFECTION; SUBCUTANEOUS HEMORRHAGE; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX PAIN; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; DATABASES, FACTUAL; DISABILITY EVALUATION; FEMALE; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; PARAPARESIS, TROPICAL SPASTIC; PRODUCT SURVEILLANCE, POSTMARKETING; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 34548606973     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280701397627     Document Type: Article

References (12)

1. Izumo, S., Goto, I., Itoyama, Y., Okajima, T., Watanabe, S., Kuroda, Y., Araki, S., Mori, M., Nagataki, S., Matsukura, S., Akamine, T., Nakagawa, M., Yamamoto, I. and Osame, M. (1996) Interferon-alpha is effective in HTLV- I-associated myelopathy: A multicenter, randomized, double-blind, controlled trial. Neurology, 46, pp. 1016-1021.
2. Matsuzaki, T., Nakagawa, M., Nagai, M., Usuku, K., Higuchi, I., Arimura, K., Kubota, H., Izumo, S., Akiba, S. and Osame, M. (2001) HTLV-I proviral load correlates with progression of motor disability in HAM/ TSP: Analysis of 239 HAM/TSP patients including 64 patients followed up for 10 years. J NeuroVirol, 7, pp. 228-234.
3. Nagai, M., Usuku, K., Matsumoto, W., Kodama, D., Takenouchi, N., Moritoyo, T., Hashiguchi, S., Ichinose, M., Bangham, C. R., Izumo, S. and Osame, M. (1998) Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: High proviral load strongly predisposes to HAM/TSP. J NeuroVirol, 4, pp. 586-593.
4. Nakagawa, M., Higashi, K., Matsuzaki, T. and Saito, M. (2004) Prognosis of 314 patients with HAM and HTLV-I proviral load. Sogo Rinsho, 53, pp. 2103-2110.
5. Nakagawa, M., Izumo, S., Ijichi, S., Kubota, H., Arimura, K., Kawabata, M. and Osame, M. (1995) HTLV-I-associated myelopathy: Analysis of 213 patients based on clinical features and laboratory findings. J NeuroVirol, 1, pp. 50-61.
6. Nakagawa, M., Nakahara, K., Maruyama, Y., Kawabata, M., Higuchi, I., Kubota, H., Izumo, S., Arimura, K. and Osame, M. (1996) Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. J NeuroVirol, 2, pp. 345-355.
7. Osame, M. (1990) Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP. Human retrovirology: HTLV, pp. 191-197. Raven Press, New York
8. Osame, M., Matsumoto, M., Usuku, K., Izumo, S., Ijichi, N., Amitani, H., Tara, M. and Igata, A. (1987) Chronic progressive myelopathy associated with elevated antibodies to HTLV-I and adult T-cell leukemia-like cells. Ann Neurol, 21, pp. 117-122.
9. Osame, M. and McArthur, J. C. (1992) Neurological manifestations of infection with human T cell lymphotropic virus type I. Diseases of the nervous system: Clinical neurobiology, pp. 1331-1339. WB Saunders, Philadelphia
10. Saito, M., Nakagawa, M., Kaseda, S., Matsuzaki, T., Jonosono, M., Eiraku, N., Kubota, R., Takenouchi, N., Nagai, M., Furukawa, Y., Usuku, K., Izumo, S. and Osame, M. (2004) Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-a therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis, 189, pp. 29-40.
11. Thierry, V. and Jacques, D. (1994) Clinical toxicity of the interferons. Drug Safety, 10, pp. 115-150.
12. Yamasaki, K., Kira, J., Koyanagi, Y., Kawano, Y., Miyano-Kurosaki, N., Nakamura, M., Baba, E., Suzuki, J., Yamamoto, A., Yamamoto, N. and Kobayashi, T. (1997) Long-term, high dose interferon-alpha treatment in HTLV-I-associated myelopathy/tropical spastic paraparesis: A combined clinical, virological and immunological study. J Neurol Sci, 147, pp. 135-144.